Showing posts with label Pediatric Bipolar Disorder. Show all posts
Showing posts with label Pediatric Bipolar Disorder. Show all posts

Sunday, October 12, 2008

The long, wild ride of bipolar disorder - A severe childhood mood disorder often lasts into young adulthood

Children who grow up with the psychiatric ailment known as bipolar disorder rarely grow out of it. Almost half of youngsters who suffered from bipolar’s severe, rapid-fire mood swings at around age 11 displayed much of the same emotional volatility at ages 18 to 20, even if the condition had improved for a while during their teens, according to the first long-term study of children diagnosed with the disorder.

Bipolar disorder took off with a vengeance in these kids. Initial episodes, often periods of frequent, dramatic mood swings, lasted for up to three years. Second episodes lasted for slightly more than one year, while third episodes continued for roughly 10 months.

During these periods, youngsters can veer back and forth several times a day between a manic sense of euphoria and a serious, even suicidal depression, say psychiatrist Barbara Geller of Washington University in St. Louis and her colleagues. Manic euphoria typically includes grandiose delusions or hallucinations.

READ MORE @ SCIENCE NEWS

Thursday, August 14, 2008

FDA Psychiatry Chief Refuses To Address Questions About Pediatric Bipolar Disorder

Two weeks ago, the FDA announced that pediatric bipolar disorder--aka, child bipolar disorder, juvenile bipolar disorder, etc.--was a valid diagnosis, despite the fact that it doesn't exist in the DSM and child psychiatrists cannot even agree amongst themselves whether the disorder exists, whether it's a proxy term for something else, and what its exact symptomology might be much less its supposed pathology. The announcement occurred in an odd way--one of the inventors of child bipolar disorder, Harvard's Janet Wozniak, asserted in a letter to the editor of the Boston Globe that the FDA considered "pediatric bipolar disorder"--her term--a valid diagnosis. That was news to me, so I queried the FDA and was told that, why yes indeedy, the agency considered the diagnosis real. Despite approving two drugs (Risperdal and Abilify, both atypical antipsychotics) for the treatment of pediatric bipolar disorder in kids aged 10 to 17 in the last year, the agency had not taken any sort of public stance on the existence of the disorder in kids and teens. Now it has.

READ MORE @ FURIOUS SEASONS